William Blair, Sofi and Affirm
Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...
Equities researchers at William Blair raised their FY2024 EPS estimates for shares of Moderna in a research report issued to ...
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
Stock Trading Recap. On Friday, Tenaya Therapeutics Inc (TNYA) stock saw a modest uptick, ending the day at $1.4 which represents a slight increase ...
Equities research analysts at William Blair cut their FY2024 earnings per share estimates for shares of MarketAxess in a ...
William Blair Small-Mid Cap Growth Fund earns a Below Average Process Pillar rating. The process benefits from its parent firm's long-term risk-adjusted performance, as shown by the firm's average ...
On Friday, Generation Bio Co (GBIO) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.96 and touched a low of $0.94 ...
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...
Portillo’s has never been one to follow the worn path in quick service. It hasn’t engaged in the “value wars” or materially ...
William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...